Lv5
914 积分 2023-06-13 加入
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells
22天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
2个月前
已完结
Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma
3个月前
已完结
CD70 CXCR2-Modified CAR T-Cells Against Acute Myeloid Leukemia
3个月前
已完结
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
3个月前
已完结
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML
3个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
4个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
4个月前
已完结
In vivo CD19-CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
4个月前
已完结
皖公网安备34019202002308
